NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Massachusetts on behalf of all persons or entities who purchased or otherwise acquired Verve Therapeutics, Inc. (“Verve” or the “Company”) (NASDAQ: VERV) securities between August 9, 2022 and April 1, 2024, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company’s investors under the federal ...